Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming November 28 Deadline in the Class Action Law...
November 23 2016 - 1:49PM
Business Wire
Law Offices of Howard G. Smith reminds investors of the
upcoming November 28, 2016 deadline to file a lead
plaintiff motion in the class action lawsuit filed on behalf of
investors who purchased or otherwise acquired Seres Therapeutics,
Inc. (“Seres” or the “Company”) (NASDAQ: MCRB) securities between
June 25, 2015 and July 29, 2016, inclusive (the “Class
Period”). Seres investors have until November 28,
2016 to file a lead plaintiff motion.
According to the complaint filed in this lawsuit, throughout the
Class Period defendants issued false and misleading statements to
investors that Seres Therapeutics advertised and hyped its lead
drug product candidate SER-109 as “novel class of biological drugs”
and a potential “first-in-field drug” despite knowledge that the
Phase 2 clinical trial of SER-109 would fail to achieve its primary
endpoint as compared to placebo. When the true details entered the
market, the lawsuit claims that investors suffered damages.
If you purchased Seres shares, you may move the Court no later
than November 28, 2016 to request appointment as
lead plaintiff. To be a member of the class you need not take any
action at this time; you may retain counsel of your choice or take
no action and remain an absent member of the Class. If you wish
to learn more about this action, or if you have any
questions concerning this announcement or your rights or interests
with respect to these matters, please contact Howard G. Smith,
Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike,
Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215)
638-4847, toll-free at (888) 638-4847, or by email to
howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161123005650/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Apr 2023 to Apr 2024